Sotac Pharmaceuticals Stock

Sotac Pharmaceuticals Tax Expense

The Income Tax Expense of Sotac Pharmaceuticals (SOTAC.NS) as of Aug 17, 2026 is 18.44 M INR. In the previous year, Income Tax Expense was 3.85 M INR — a change of 379.54% (higher).

Tax Expense

18.44 MINR

YoY

379.54%

Last updated:

Income Tax Expense of Sotac Pharmaceuticals is 2026 18.44 M INR. Income Tax Expense of Sotac Pharmaceuticals was 2025 3.85 M INR. It decreases by 379.54% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Sotac Pharmaceuticals Stock analysis

What does Sotac Pharmaceuticals do? Sotac Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sotac Pharmaceuticals stock

Income Tax Expense of Sotac Pharmaceuticals is 18.44 M INR in 2026.

Income Tax Expense of Sotac Pharmaceuticals changed from 3.85 M INR to 18.44 M INR, representing a 379.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Income Tax Expense Sotac Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Tax expense represents the total income taxes owed. It reflects the company's tax obligations and effective tax rate.

Income Tax Expense's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Income Tax Expense's Sotac Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Sotac Pharmaceuticals

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Sotac Pharmaceuticals